ULtra sensiTive ctDNA-Informed Management eArly-stage recTal cancEr (ULTIMATE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07209215

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:36.527973+00:00

Published At

2026-01-20T00:00:00+00:00

Record Updated At

2026-01-20

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Rectal Adenocarcinoma", "Rectal Cancer", "Early-stage Rectal Cancer", "Locally Advanced Rectal Adenocarcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-01-20"

protocolSection.identificationModule.nctId

"NCT07209215"

protocolSection.identificationModule.officialTitle

"ULtra sensiTive ctDNA-Informed Management eArly-stage recTal cancEr (ULTIMATE)"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Rectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Rectal Cancer (protocolSection.conditionsModule.conditions)
• Early-stage Rectal Cancer (protocolSection.conditionsModule.conditions)
• Locally Advanced Rectal Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.